Daxor
DXR
9 hedge funds and large institutions have $1.76M invested in Daxor in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
0.1% more ownership
Funds ownership: 6.17% → 6.28% (+0.1%)
16% less capital invested
Capital invested by funds: $2.1M → $1.76M (-$338K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$4.92K |
| 2 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$2.41K |
| 3 |
Renaissance Technologies
New York
|
+$2.36K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$126 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| 2 |
Morgan Stanley
New York
|
-$433 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$8 |
DXR Hedge Fund Activity: Q2 2014 in Review
9 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2014, worth a combined $1.76M — down 16% from $2.1M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new DXR positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS, adding an estimated $4.92K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $2K sold.
- 9 institutional investors held Daxor (DXR) as of Q2 2014, up from 8 in Q1 2014.
- Funds reported $1.76M of Daxor stock for Q2 2014, down 16% quarter-over-quarter.
- 3 funds opened new Daxor positions in Q2 2014 and 2 closed out, a net change of +1 holder.
- The largest Daxor buyer in Q2 2014 was UBS, an estimated $4.92K added.
- The largest Daxor seller in Q2 2014 was Tower Research Capital (TRC), an estimated $2K sold.
Based on aggregated 13F filings for Q2 2014.